| _version_ | 1867009887665389568 |
|---|---|
| author | Steve Chaplin |
| author_facet | Steve Chaplin Steve Chaplin |
| collection | Wiley Open Access |
| contents | Mavacamten for obstructive hypertrophic cardiomyopathy Steve Chaplin Prescriber Mavacamten (Camzyos) is a cardiac myosin inhibitor indicated for the treatment of symptomatic obstructive hypertrophic cardiomyopathy. This article discusses its efficacy, adverse effects and place in therapy. 10.1002/psb.2113 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/psb.2113 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_psb_2113 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Mavacamten for obstructive hypertrophic cardiomyopathy Steve Chaplin Prescriber Mavacamten for obstructive hypertrophic cardiomyopathy Steve Chaplin Prescriber Mavacamten (Camzyos) is a cardiac myosin inhibitor indicated for the treatment of symptomatic obstructive hypertrophic cardiomyopathy. This article discusses its efficacy, adverse effects and place in therapy. 10.1002/psb.2113 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Mavacamten for obstructive hypertrophic cardiomyopathy |
| topic | Prescriber |
| url | https://wchh.onlinelibrary.wiley.com/doi/10.1002/psb.2113 |